©2024 Stanford Medicine
Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy
Not Recruiting
Trial ID: NCT02203565
Purpose
This pilot clinical trial studies Dakin's solution in preventing radiation dermatitis in
patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a skin
condition in which the affected skin becomes painful, red, itchy, and blistered. Dakin's
solution may help reduce dermatitis caused by radiation therapy.
Official Title
Pilot Study to Investigate the Impact of Hypochlorite in the Prevention of Radiation Dermatitis
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
- Women with breast cancer who plan to undergo radiation therapy to the breast or chest
wall
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Women with scleroderma or discoid lupus
- Women with inflammatory breast cancer as evidenced by clinical assessment
- Women with breast cancer involving the skin
- Women who have undergone prior radiotherapy to the chest wall and/or breast
Intervention(s):
drug: Dakin's solution
radiation: radiation therapy
other: questionnaire administration
other: laboratory biomarker analysis
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Amanda Simmons
650-724-4606